N-[3-(diethylamino)propyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-[2-(dimethylamino)ethyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;2-[2-methoxy-4-[6-(1-pyridin-3-ylbutylamino)pyrazin-2-yl]phenyl]-1-piperidin-4-ylethanone;1-[2-methoxy-4-[6-[(2R)-2-pyridin-3-ylbutyl]pyrazin-2-yl]phenyl]pentan-2-one;(4-methylpiperazin-1-yl)-[4-[6-(2-phenylpentyl)pyrazin-2-yl]phenyl]methanone;N-(3-morpholin-4-ylpropyl)-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-(1-phenylbutyl)-6-[4-(pyrrolidin-1-ylmethyl)phenyl]pyrazin-2-amine

C185H227N31O9 — CID 159917092

IUPACN-[3-(diethylamino)propyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-[2-(dimethylamino)ethyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;2-[2-methoxy-4-[6-(1-pyridin-3-ylbutylamino)pyrazin-2-yl]phenyl]-1-piperidin-4-ylethanone;1-[2-methoxy-4-[6-[(2R)-2-pyridin-3-ylbutyl]pyrazin-2-yl]phenyl]pentan-2-one;(4-methylpiperazin-1-yl)-[4-[6-(2-phenylpentyl)pyrazin-2-yl]phenyl]methanone;N-(3-morpholin-4-ylpropyl)-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-(1-phenylbutyl)-6-[4-(pyrrolidin-1-ylmethyl)phenyl]pyrazin-2-amine
SMILESCCCC(=O)Cc1ccc(-c2cncc(C[C@@H](CC)c3cccnc3)n2)cc1OC.CCCC(Cc1cncc(-c2ccc(C(=O)N3CCN(C)CC3)cc2)n1)c1ccccc1.CCCC(Nc1cncc(-c2ccc(C(=O)NCCCN(CC)CC)cc2)n1)c1ccccc1.CCCC(Nc1cncc(-c2ccc(C(=O)NCCCN3CCOCC3)cc2)n1)c1ccccc1.CCCC(Nc1cncc(-c2ccc(C(=O)NCCN(C)C)cc2)n1)c1ccccc1.CCCC(Nc1cncc(-c2ccc(CC(=O)C3CCNCC3)c(OC)c2)n1)c1cccnc1.CCCC(Nc1cncc(-c2ccc(CN3CCCC3)cc2)n1)c1ccccc1
InChIInChI=1S/C28H35N5O2.C28H37N5O.C27H33N5O2.C27H32N4O.C25H31N5O.C25H30N4.C25H29N3O2/c1-2-7-25(22-8-4-3-5-9-22)31-27-21-29-20-26(32-27)23-10-12-24(13-11-23)28(34)30-14-6-15-33-16-18-35-19-17-33;1-4-11-25(22-12-8-7-9-13-22)31-27-21-29-20-26(32-27)23-14-16-24(17-15-23)28(34)30-18-10-19-33(5-2)6-3;1-3-5-23(22-6-4-11-29-16-22)31-27-18-30-17-24(32-27)20-7-8-21(26(15-20)34-2)14-25(33)19-9-12-28-13-10-19;1-3-7-24(21-8-5-4-6-9-21)18-25-19-28-20-26(29-25)22-10-12-23(13-11-22)27(32)31-16-14-30(2)15-17-31;1-4-8-22(19-9-6-5-7-10-19)28-24-18-26-17-23(29-24)20-11-13-21(14-12-20)25(31)27-15-16-30(2)3;1-2-8-23(21-9-4-3-5-10-21)27-25-18-26-17-24(28-25)22-13-11-20(12-14-22)19-29-15-6-7-16-29;1-4-7-23(29)13-20-10-9-19(14-25(20)30-3)24-17-27-16-22(28-24)12-18(5-2)21-8-6-11-26-15-21/h3-5,8-13,20-21,25H,2,6-7,14-19H2,1H3,(H,30,34)(H,31,32);7-9,12-17,20-21,25H,4-6,10-11,18-19H2,1-3H3,(H,30,34)(H,31,32);4,6-8,11,15-19,23,28H,3,5,9-10,12-14H2,1-2H3,(H,31,32);4-6,8-13,19-20,24H,3,7,14-18H2,1-2H3;5-7,9-14,17-18,22H,4,8,15-16H2,1-3H3,(H,27,31)(H,28,29);3-5,9-14,17-18,23H,2,6-8,15-16,19H2,1H3,(H,27,28);6,8-11,14-18H,4-5,7,12-13H2,1-3H3/t;;;;;;18-/m......1/s1
InChIKeyNXXOLPSVTWFSNY-UQTKDWPTSA-N
MW3029.06 g/mol
LogP34.65
Rot. Bonds69

About N-[3-(diethylamino)propyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-[2-(dimethylamino)ethyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;2-[2-methoxy-4-[6-(1-pyridin-3-ylbutylamino)pyrazin-2-yl]phenyl]-1-piperidin-4-ylethanone;1-[2-methoxy-4-[6-[(2R)-2-pyridin-3-ylbutyl]pyrazin-2-yl]phenyl]pentan-2-one;(4-methylpiperazin-1-yl)-[4-[6-(2-phenylpentyl)pyrazin-2-yl]phenyl]methanone;N-(3-morpholin-4-ylpropyl)-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-(1-phenylbutyl)-6-[4-(pyrrolidin-1-ylmethyl)phenyl]pyrazin-2-amine

N-[3-(diethylamino)propyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-[2-(dimethylamino)ethyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;2-[2-methoxy-4-[6-(1-pyridin-3-ylbutylamino)pyrazin-2-yl]phenyl]-1-piperidin-4-ylethanone;1-[2-methoxy-4-[6-[(2R)-2-pyridin-3-ylbutyl]pyrazin-2-yl]phenyl]pentan-2-one;(4-methylpiperazin-1-yl)-[4-[6-(2-phenylpentyl)pyrazin-2-yl]phenyl]methanone;N-(3-morpholin-4-ylpropyl)-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-(1-phenylbutyl)-6-[4-(pyrrolidin-1-ylmethyl)phenyl]pyrazin-2-amine (PubChem CID 159917092) has the molecular formula C185H227N31O9 and a molecular weight of 3029.06 g/mol. Its IUPAC name is N-[3-(diethylamino)propyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-[2-(dimethylamino)ethyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;2-[2-methoxy-4-[6-(1-pyridin-3-ylbutylamino)pyrazin-2-yl]phenyl]-1-piperidin-4-ylethanone;1-[2-methoxy-4-[6-[(2R)-2-pyridin-3-ylbutyl]pyrazin-2-yl]phenyl]pentan-2-one;(4-methylpiperazin-1-yl)-[4-[6-(2-phenylpentyl)pyrazin-2-yl]phenyl]methanone;N-(3-morpholin-4-ylpropyl)-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-(1-phenylbutyl)-6-[4-(pyrrolidin-1-ylmethyl)phenyl]pyrazin-2-amine.

Molecular Properties

Compound NameN-[3-(diethylamino)propyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-[2-(dimethylamino)ethyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;2-[2-methoxy-4-[6-(1-pyridin-3-ylbutylamino)pyrazin-2-yl]phenyl]-1-piperidin-4-ylethanone;1-[2-methoxy-4-[6-[(2R)-2-pyridin-3-ylbutyl]pyrazin-2-yl]phenyl]pentan-2-one;(4-methylpiperazin-1-yl)-[4-[6-(2-phenylpentyl)pyrazin-2-yl]phenyl]methanone;N-(3-morpholin-4-ylpropyl)-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-(1-phenylbutyl)-6-[4-(pyrrolidin-1-ylmethyl)phenyl]pyrazin-2-amine
PubChem CID159917092
Molecular FormulaC185H227N31O9
Molecular Weight3029.06 g/mol
Exact Mass3026.83
IUPAC NameN-[3-(diethylamino)propyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-[2-(dimethylamino)ethyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;2-[2-methoxy-4-[6-(1-pyridin-3-ylbutylamino)pyrazin-2-yl]phenyl]-1-piperidin-4-ylethanone;1-[2-methoxy-4-[6-[(2R)-2-pyridin-3-ylbutyl]pyrazin-2-yl]phenyl]pentan-2-one;(4-methylpiperazin-1-yl)-[4-[6-(2-phenylpentyl)pyrazin-2-yl]phenyl]methanone;N-(3-morpholin-4-ylpropyl)-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-(1-phenylbutyl)-6-[4-(pyrrolidin-1-ylmethyl)phenyl]pyrazin-2-amine
SMILESCCCC(=O)Cc1ccc(-c2cncc(C[C@@H](CC)c3cccnc3)n2)cc1OC.CCCC(Cc1cncc(-c2ccc(C(=O)N3CCN(C)CC3)cc2)n1)c1ccccc1.CCCC(Nc1cncc(-c2ccc(C(=O)NCCCN(CC)CC)cc2)n1)c1ccccc1.CCCC(Nc1cncc(-c2ccc(C(=O)NCCCN3CCOCC3)cc2)n1)c1ccccc1.CCCC(Nc1cncc(-c2ccc(C(=O)NCCN(C)C)cc2)n1)c1ccccc1.CCCC(Nc1cncc(-c2ccc(CC(=O)C3CCNCC3)c(OC)c2)n1)c1cccnc1.CCCC(Nc1cncc(-c2ccc(CN3CCCC3)cc2)n1)c1ccccc1
InChIInChI=1S/C28H35N5O2.C28H37N5O.C27H33N5O2.C27H32N4O.C25H31N5O.C25H30N4.C25H29N3O2/c1-2-7-25(22-8-4-3-5-9-22)31-27-21-29-20-26(32-27)23-10-12-24(13-11-23)28(34)30-14-6-15-33-16-18-35-19-17-33;1-4-11-25(22-12-8-7-9-13-22)31-27-21-29-20-26(32-27)23-14-16-24(17-15-23)28(34)30-18-10-19-33(5-2)6-3;1-3-5-23(22-6-4-11-29-16-22)31-27-18-30-17-24(32-27)20-7-8-21(26(15-20)34-2)14-25(33)19-9-12-28-13-10-19;1-3-7-24(21-8-5-4-6-9-21)18-25-19-28-20-26(29-25)22-10-12-23(13-11-22)27(32)31-16-14-30(2)15-17-31;1-4-8-22(19-9-6-5-7-10-19)28-24-18-26-17-23(29-24)20-11-13-21(14-12-20)25(31)27-15-16-30(2)3;1-2-8-23(21-9-4-3-5-10-21)27-25-18-26-17-24(28-25)22-13-11-20(12-14-22)19-29-15-6-7-16-29;1-4-7-23(29)13-20-10-9-19(14-25(20)30-3)24-17-27-16-22(28-24)12-18(5-2)21-8-6-11-26-15-21/h3-5,8-13,20-21,25H,2,6-7,14-19H2,1H3,(H,30,34)(H,31,32);7-9,12-17,20-21,25H,4-6,10-11,18-19H2,1-3H3,(H,30,34)(H,31,32);4,6-8,11,15-19,23,28H,3,5,9-10,12-14H2,1-2H3,(H,31,32);4-6,8-13,19-20,24H,3,7,14-18H2,1-2H3;5-7,9-14,17-18,22H,4,8,15-16H2,1-3H3,(H,27,31)(H,28,29);3-5,9-14,17-18,23H,2,6-8,15-16,19H2,1H3,(H,27,28);6,8-11,14-18H,4-5,7,12-13H2,1-3H3/t;;;;;;18-/m......1/s1
InChIKeyNXXOLPSVTWFSNY-UQTKDWPTSA-N
XLogP34.65
TPSA464.06 Ų
H-Bond Donors9
H-Bond Acceptors36
Rotatable Bonds69
Heavy Atoms225
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003029.06
LogP ≤ 534.65
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1036

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[3-(diethylamino)propyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-[2-(dimethylamino)ethyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;2-[2-methoxy-4-[6-(1-pyridin-3-ylbutylamino)pyrazin-2-yl]phenyl]-1-piperidin-4-ylethanone;1-[2-methoxy-4-[6-[(2R)-2-pyridin-3-ylbutyl]pyrazin-2-yl]phenyl]pentan-2-one;(4-methylpiperazin-1-yl)-[4-[6-(2-phenylpentyl)pyrazin-2-yl]phenyl]methanone;N-(3-morpholin-4-ylpropyl)-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-(1-phenylbutyl)-6-[4-(pyrrolidin-1-ylmethyl)phenyl]pyrazin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-(8-amino-3-((7R,9aS)-2-isonicotinoyl-4-oxooctahydro-1H-pyrido[1,2-a]pyrazin-7-yl)imidazo[1,5-a]pyrazin-1-yl)-3-methoxy-N-(4-(trifluoromethyl)pyridin-2-yl)benzamide
CID 77107252
US10343992, Example 41
CID 122590880
N-[3-(3-methoxyphenyl)-6-[4-(morpholine-4-carbonyl)phenyl]imidazo[1,2-a]pyridin-8-yl]acetamide
CID 49791186
3-(3-methoxyphenyl)-2-(4-morpholin-4-ylpiperidin-1-yl)-N-(2-pyridin-3-ylethyl)quinoxaline-6-carboxamide
CID 118453908
3-(3-methoxyphenyl)-2-(4-morpholin-4-ylpiperidin-1-yl)-N-(3-pyridin-3-ylpropyl)quinoxaline-6-carboxamide
CID 118463576
4-methyl-3-[3-[2-(3-morpholin-4-ylpropylamino)pyridin-4-yl]pyridin-2-yl]oxy-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]benzamide
CID 67353579
N-[(3-tert-butylphenyl)methyl]-3-[[6-[2-(dimethylamino)ethyl-methylamino]-1-[[4-[[4-methoxy-3-(trifluoromethyl)phenyl]carbamoyl]-2-[[1-[[4-[[4-methoxy-3-(trifluoromethyl)phenyl]carbamoyl]-2-[[6-(4-methylpiperazin-1-yl)pyrimido[5,4-d]pyrimidin-4-yl]amino]phenyl]methyl]-6-morpholin-4-ylpyrimido[5,4-d]pyrimidin-1-ium-4-yl]amino]phenyl]methyl]pyrimido[5,4-d]pyrimidin-1-ium-4-yl]amino]-4-methylbenzamide
CID 90936133
3-[[6-[4-(2,6-dimethylmorpholin-4-yl)piperidin-1-yl]-1-[[4-[[4-methoxy-3-(trifluoromethyl)phenyl]carbamoyl]-2-[[1-[[4-[[4-methoxy-3-(trifluoromethyl)phenyl]carbamoyl]-2-[[6-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]pyrimido[5,4-d]pyrimidin-4-yl]amino]phenyl]methyl]-6-(4-morpholin-4-ylpiperidin-1-yl)pyrimido[5,4-d]pyrimidin-1-ium-4-yl]amino]phenyl]methyl]pyrimido[5,4-d]pyrimidin-1-ium-4-yl]amino]-N-[4-methoxy-3-(trifluoromethyl)phenyl]-4-methylbenzamide
CID 90971367
3-[6-[4-(2-methoxyethyl)piperazin-1-yl]-4-[5-[[4-methoxy-3-(trifluoromethyl)phenyl]carbamoyl]-N,2-dimethylanilino]pyrimido[5,4-d]pyrimidin-1-ium-1-yl]-N-[4-methoxy-3-(trifluoromethyl)phenyl]-5-[[1-[[4-[[4-methoxy-3-(trifluoromethyl)phenyl]carbamoyl]-2-[methyl-(6-morpholin-4-ylpyrimido[5,4-d]pyrimidin-4-yl)amino]phenyl]methyl]-6-(oxolan-3-ylamino)pyrimido[5,4-d]pyrimidin-1-ium-4-yl]-methylamino]-4-methylbenzamide
CID 90990081
2-fluoro-4-[[(4S)-4-methyl-2-oxopyrrolidin-1-yl]methyl]-5-[4-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]phenoxy]-N-[1-(oxan-4-yl)piperidin-4-yl]benzamide
CID 118465393
4-[8-amino-3-[(2R,5S)-4-[1-[(2,6-difluorophenyl)methyl]azetidine-3-carbonyl]-5-methylmorpholin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-3-methoxy-N-[4-(trifluoromethyl)pyridin-2-yl]benzamide
CID 121455089
4-[8-amino-3-[(2R,5S)-5-methyl-4-(oxan-4-yl)morpholin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-3-methoxy-N-[4-(trifluoromethyl)pyridin-2-yl]benzamide
CID 121455102

Frequently Asked Questions

What is the IUPAC name of N-[3-(diethylamino)propyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-[2-(dimethylamino)ethyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;2-[2-methoxy-4-[6-(1-pyridin-3-ylbutylamino)pyrazin-2-yl]phenyl]-1-piperidin-4-ylethanone;1-[2-methoxy-4-[6-[(2R)-2-pyridin-3-ylbutyl]pyrazin-2-yl]phenyl]pentan-2-one;(4-methylpiperazin-1-yl)-[4-[6-(2-phenylpentyl)pyrazin-2-yl]phenyl]methanone;N-(3-morpholin-4-ylpropyl)-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-(1-phenylbutyl)-6-[4-(pyrrolidin-1-ylmethyl)phenyl]pyrazin-2-amine?
The IUPAC name of N-[3-(diethylamino)propyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-[2-(dimethylamino)ethyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;2-[2-methoxy-4-[6-(1-pyridin-3-ylbutylamino)pyrazin-2-yl]phenyl]-1-piperidin-4-ylethanone;1-[2-methoxy-4-[6-[(2R)-2-pyridin-3-ylbutyl]pyrazin-2-yl]phenyl]pentan-2-one;(4-methylpiperazin-1-yl)-[4-[6-(2-phenylpentyl)pyrazin-2-yl]phenyl]methanone;N-(3-morpholin-4-ylpropyl)-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-(1-phenylbutyl)-6-[4-(pyrrolidin-1-ylmethyl)phenyl]pyrazin-2-amine (CID 159917092) is N-[3-(diethylamino)propyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-[2-(dimethylamino)ethyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;2-[2-methoxy-4-[6-(1-pyridin-3-ylbutylamino)pyrazin-2-yl]phenyl]-1-piperidin-4-ylethanone;1-[2-methoxy-4-[6-[(2R)-2-pyridin-3-ylbutyl]pyrazin-2-yl]phenyl]pentan-2-one;(4-methylpiperazin-1-yl)-[4-[6-(2-phenylpentyl)pyrazin-2-yl]phenyl]methanone;N-(3-morpholin-4-ylpropyl)-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-(1-phenylbutyl)-6-[4-(pyrrolidin-1-ylmethyl)phenyl]pyrazin-2-amine.
What is the SMILES notation for N-[3-(diethylamino)propyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-[2-(dimethylamino)ethyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;2-[2-methoxy-4-[6-(1-pyridin-3-ylbutylamino)pyrazin-2-yl]phenyl]-1-piperidin-4-ylethanone;1-[2-methoxy-4-[6-[(2R)-2-pyridin-3-ylbutyl]pyrazin-2-yl]phenyl]pentan-2-one;(4-methylpiperazin-1-yl)-[4-[6-(2-phenylpentyl)pyrazin-2-yl]phenyl]methanone;N-(3-morpholin-4-ylpropyl)-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-(1-phenylbutyl)-6-[4-(pyrrolidin-1-ylmethyl)phenyl]pyrazin-2-amine?
The canonical SMILES for N-[3-(diethylamino)propyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-[2-(dimethylamino)ethyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;2-[2-methoxy-4-[6-(1-pyridin-3-ylbutylamino)pyrazin-2-yl]phenyl]-1-piperidin-4-ylethanone;1-[2-methoxy-4-[6-[(2R)-2-pyridin-3-ylbutyl]pyrazin-2-yl]phenyl]pentan-2-one;(4-methylpiperazin-1-yl)-[4-[6-(2-phenylpentyl)pyrazin-2-yl]phenyl]methanone;N-(3-morpholin-4-ylpropyl)-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-(1-phenylbutyl)-6-[4-(pyrrolidin-1-ylmethyl)phenyl]pyrazin-2-amine is CCCC(=O)Cc1ccc(-c2cncc(C[C@@H](CC)c3cccnc3)n2)cc1OC.CCCC(Cc1cncc(-c2ccc(C(=O)N3CCN(C)CC3)cc2)n1)c1ccccc1.CCCC(Nc1cncc(-c2ccc(C(=O)NCCCN(CC)CC)cc2)n1)c1ccccc1.CCCC(Nc1cncc(-c2ccc(C(=O)NCCCN3CCOCC3)cc2)n1)c1ccccc1.CCCC(Nc1cncc(-c2ccc(C(=O)NCCN(C)C)cc2)n1)c1ccccc1.CCCC(Nc1cncc(-c2ccc(CC(=O)C3CCNCC3)c(OC)c2)n1)c1cccnc1.CCCC(Nc1cncc(-c2ccc(CN3CCCC3)cc2)n1)c1ccccc1.
What is the InChIKey of N-[3-(diethylamino)propyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-[2-(dimethylamino)ethyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;2-[2-methoxy-4-[6-(1-pyridin-3-ylbutylamino)pyrazin-2-yl]phenyl]-1-piperidin-4-ylethanone;1-[2-methoxy-4-[6-[(2R)-2-pyridin-3-ylbutyl]pyrazin-2-yl]phenyl]pentan-2-one;(4-methylpiperazin-1-yl)-[4-[6-(2-phenylpentyl)pyrazin-2-yl]phenyl]methanone;N-(3-morpholin-4-ylpropyl)-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-(1-phenylbutyl)-6-[4-(pyrrolidin-1-ylmethyl)phenyl]pyrazin-2-amine?
The InChIKey is NXXOLPSVTWFSNY-UQTKDWPTSA-N. The full InChI is InChI=1S/C28H35N5O2.C28H37N5O.C27H33N5O2.C27H32N4O.C25H31N5O.C25H30N4.C25H29N3O2/c1-2-7-25(22-8-4-3-5-9-22)31-27-21-29-20-26(32-27)23-10-12-24(13-11-23)28(34)30-14-6-15-33-16-18-35-19-17-33;1-4-11-25(22-12-8-7-9-13-22)31-27-21-29-20-26(32-27)23-14-16-24(17-15-23)28(34)30-18-10-19-33(5-2)6-3;1-3-5-23(22-6-4-11-29-16-22)31-27-18-30-17-24(32-27)20-7-8-21(26(15-20)34-2)14-25(33)19-9-12-28-13-10-19;1-3-7-24(21-8-5-4-6-9-21)18-25-19-28-20-26(29-25)22-10-12-23(13-11-22)27(32)31-16-14-30(2)15-17-31;1-4-8-22(19-9-6-5-7-10-19)28-24-18-26-17-23(29-24)20-11-13-21(14-12-20)25(31)27-15-16-30(2)3;1-2-8-23(21-9-4-3-5-10-21)27-25-18-26-17-24(28-25)22-13-11-20(12-14-22)19-29-15-6-7-16-29;1-4-7-23(29)13-20-10-9-19(14-25(20)30-3)24-17-27-16-22(28-24)12-18(5-2)21-8-6-11-26-15-21/h3-5,8-13,20-21,25H,2,6-7,14-19H2,1H3,(H,30,34)(H,31,32);7-9,12-17,20-21,25H,4-6,10-11,18-19H2,1-3H3,(H,30,34)(H,31,32);4,6-8,11,15-19,23,28H,3,5,9-10,12-14H2,1-2H3,(H,31,32);4-6,8-13,19-20,24H,3,7,14-18H2,1-2H3;5-7,9-14,17-18,22H,4,8,15-16H2,1-3H3,(H,27,31)(H,28,29);3-5,9-14,17-18,23H,2,6-8,15-16,19H2,1H3,(H,27,28);6,8-11,14-18H,4-5,7,12-13H2,1-3H3/t;;;;;;18-/m......1/s1.
What are the key properties of N-[3-(diethylamino)propyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-[2-(dimethylamino)ethyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;2-[2-methoxy-4-[6-(1-pyridin-3-ylbutylamino)pyrazin-2-yl]phenyl]-1-piperidin-4-ylethanone;1-[2-methoxy-4-[6-[(2R)-2-pyridin-3-ylbutyl]pyrazin-2-yl]phenyl]pentan-2-one;(4-methylpiperazin-1-yl)-[4-[6-(2-phenylpentyl)pyrazin-2-yl]phenyl]methanone;N-(3-morpholin-4-ylpropyl)-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-(1-phenylbutyl)-6-[4-(pyrrolidin-1-ylmethyl)phenyl]pyrazin-2-amine?
N-[3-(diethylamino)propyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-[2-(dimethylamino)ethyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;2-[2-methoxy-4-[6-(1-pyridin-3-ylbutylamino)pyrazin-2-yl]phenyl]-1-piperidin-4-ylethanone;1-[2-methoxy-4-[6-[(2R)-2-pyridin-3-ylbutyl]pyrazin-2-yl]phenyl]pentan-2-one;(4-methylpiperazin-1-yl)-[4-[6-(2-phenylpentyl)pyrazin-2-yl]phenyl]methanone;N-(3-morpholin-4-ylpropyl)-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-(1-phenylbutyl)-6-[4-(pyrrolidin-1-ylmethyl)phenyl]pyrazin-2-amine has a molecular weight of 3029.06 g/mol, XLogP of 34.65, 69 rotatable bonds, 9 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(diethylamino)propyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-[2-(dimethylamino)ethyl]-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;2-[2-methoxy-4-[6-(1-pyridin-3-ylbutylamino)pyrazin-2-yl]phenyl]-1-piperidin-4-ylethanone;1-[2-methoxy-4-[6-[(2R)-2-pyridin-3-ylbutyl]pyrazin-2-yl]phenyl]pentan-2-one;(4-methylpiperazin-1-yl)-[4-[6-(2-phenylpentyl)pyrazin-2-yl]phenyl]methanone;N-(3-morpholin-4-ylpropyl)-4-[6-(1-phenylbutylamino)pyrazin-2-yl]benzamide;N-(1-phenylbutyl)-6-[4-(pyrrolidin-1-ylmethyl)phenyl]pyrazin-2-amine is sourced from PubChem (CID 159917092), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).